Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -672.16% is 23% above its 5-year average of -872.61%, near the low end of its 5-year range (-2112.62%–6894.16%).
13.69% above its 12-month average of -778.78%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1392.27%.
NET PROFIT MARGIN
-672.16%
NET PROFIT MARGIN AVG TTM
-778.78%
NET PROFIT MARGIN AVG 3Y
-852.06%
NET PROFIT MARGIN AVG 5Y
-872.61%
NET PROFIT MARGIN AVG 10Y
-566.53%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+13.69%
CURRENT VS 3Y AVG
+21.11%
CURRENT VS 5Y AVG
+22.97%
CURRENT VS 10Y AVG
-18.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-7843.78%
vs the sector median at left
Intellia Therapeutics, Inc.
Market Cap
$1.72B
Net Profit Margin
-672.16%
TTM Avg
-778.78%
3Y Avg
-852.06%
5Y Avg
-872.61%
Market Cap
$1.73B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$2.14B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$1.00B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$2.51B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.74B
Net Profit Margin
22.69%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$472.39M
Net Profit Margin
-6.77%
TTM Avg
-13.38%
3Y Avg
-17.48%
5Y Avg
-11.79%
Market Cap
$397.55M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.72B | -672.16% | -778.78% | -852.06% | -872.61% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -14.99% | -20.12% | -16.95% | -10.04% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -7.13% | -23.45% | -155.72% | -114.72% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | -54.75% | -325.19% | -290.00% | -135445.82% |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 22.69% | 19.73% | -2.42% | -44.65% |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | -6.77% | -13.38% | -17.48% | -11.79% |
| NRC Health (NRC)vs › | $459.30M | 4.18% | 12.88% | 16.89% | 20.14% |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | -58.33% | -67.34% | -66.78% | -66.78% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-651.7%
Net Profit Margin
-672.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1392.27% |
| 2026-03-31 | -639.49% |
| 2025-12-31 | -416.15% |
| 2025-09-30 | -735.19% |
| 2025-06-30 | -710.81% |
| 2025-03-31 | -687.61% |
| 2024-12-31 | -1001.23% |
| 2024-09-30 | -1489.54% |
| 2024-06-30 | -2112.62% |
| 2024-03-31 | -371.30% |
| 2023-12-31 | 6894.16% |
| 2023-09-30 | -1019.21% |
| 2023-06-30 | -909.82% |
| 2023-03-31 | -818.07% |
| 2022-12-31 | -835.53% |
| 2022-09-30 | -853.53% |
| 2022-06-30 | -717.59% |
| 2022-03-31 | -1305.30% |
| 2021-12-31 | -632.00% |
| 2021-09-30 | -994.50% |
| 2021-06-30 | -1050.47% |
| 2021-03-31 | -716.91% |
| 2020-12-31 | -639.76% |
| 2020-09-30 | -125.29% |
| 2020-06-30 | -199.18% |
| 2020-03-31 | -246.25% |
| 2019-12-31 | -258.56% |
| 2019-09-30 | -222.63% |
| 2019-06-30 | -231.00% |
| 2019-03-31 | -210.29% |
| 2018-12-31 | -241.95% |
| 2018-09-30 | -306.45% |
| 2018-06-30 | -289.42% |
| 2018-03-31 | -285.93% |
| 2017-12-31 | -359.37% |
| 2017-09-30 | -209.87% |
| 2017-06-30 | -263.53% |
| 2017-03-31 | -203.23% |
| 2016-12-31 | -187.72% |
| 2016-09-30 | -153.67% |
| 2016-06-30 | -164.05% |
| 2016-03-31 | -376.42% |
| 2015-12-31 | -309.81% |
| 2015-09-30 | -178.85% |
| 2015-06-30 | -220.77% |
| 2015-03-31 | -84.99% |
| 2014-12-31 | 0.00% |
| 2014-06-30 | 0.00% |
